A. Stratopoulos

Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.

G. Patrinos, T. Katsila, A. Sgourou, 2017, Omics : a journal of integrative biology.

Novel genetic risk variants for pediatric celiac disease

B. Peters, R. Drmanac, G. Patrinos, 2016, Human Genomics.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.

G. Patrinos, T. Katsila, A. Symeonidis, 2019, Pharmacogenomics.

Novel genetic risk variants for pediatric celiac disease

B. Peters, R. Drmanac, G. Chrousos, 2016, Human Genomics.